Bayer AG has hemorrhaged both earnings and value this year, and management has decided that only extreme measures can save the group. It has ruled out a simultaneous three-way split, but might do a staggered one. Or it might just hive off its crop science division. Or its consumer health unit. Or it might stay as it is.
Bayer To Split Off Consumer Or Crop Science, Or Both, Or Neither
After a miserable third quarter the German group is cutting jobs and considering splitting up, but concrete decisions are thin on the ground.
